中华血液学杂志
中華血液學雜誌
중화혈액학잡지
Chinese Journal of Hematology
2014年
6期
528-532
,共5页
王缦%陈翀%徐杰%王力%宋旭光%张焕新%曾令宇%徐开林
王縵%陳翀%徐傑%王力%宋旭光%張煥新%曾令宇%徐開林
왕만%진충%서걸%왕력%송욱광%장환신%증령우%서개림
溴结构域蛋白4抑制剂%RS4%11细胞%细胞增殖
溴結構域蛋白4抑製劑%RS4%11細胞%細胞增殖
추결구역단백4억제제%RS4%11세포%세포증식
Bromdomain protein 4%RS4%11 cells%Proliferation
目的 探究溴结构域蛋白4(BRD4)抑制剂对急性B淋巴细胞白血病细胞生物学行为的影响及可能机制.方法 用BRD4抑制剂GSK525762A抑制急性B淋巴细胞白血病细胞株RS4; 11细胞BRD4活性,并以急性T淋巴细胞白血病细胞株Jurkat细胞作对照.采用CCK-8法检测其对细胞增殖的影响;用Annexin Ⅴ/7-AAD标记,流式细胞术检测细胞凋亡;荧光定量PCR检测抗凋亡基因c-myc、Bcl-2、CDK6和促凋亡基因Bad、Bak、Bax的转录水平;Western blot检测Bcl-2及Bak蛋白的表达.结果 不同浓度GSK525762A对RS4; 11细胞增殖均有抑制作用,且呈时间和剂量依赖性,作用48、72 h其半数抑制率分别为6.174和1.996 μmol/L.与DMSO处理组比较,GSK525762A处理后RS4; 11细胞c-myc、Bcl-2、CDK6mRNA转录水平降低,而Bad、Bak、Bax mRNA转录水平升高,且Bcl-2蛋白表达水平下调,Bak蛋白表达水平上调.而GSK525762A对Jurkat细胞的增殖抑制作用并不明显.结论 GSK525762A可抑制RS4; 11细胞的增殖,并促进其凋亡;该作用可能通过下调Bcl-2表达,诱导白血病细胞凋亡而实现的.
目的 探究溴結構域蛋白4(BRD4)抑製劑對急性B淋巴細胞白血病細胞生物學行為的影響及可能機製.方法 用BRD4抑製劑GSK525762A抑製急性B淋巴細胞白血病細胞株RS4; 11細胞BRD4活性,併以急性T淋巴細胞白血病細胞株Jurkat細胞作對照.採用CCK-8法檢測其對細胞增殖的影響;用Annexin Ⅴ/7-AAD標記,流式細胞術檢測細胞凋亡;熒光定量PCR檢測抗凋亡基因c-myc、Bcl-2、CDK6和促凋亡基因Bad、Bak、Bax的轉錄水平;Western blot檢測Bcl-2及Bak蛋白的錶達.結果 不同濃度GSK525762A對RS4; 11細胞增殖均有抑製作用,且呈時間和劑量依賴性,作用48、72 h其半數抑製率分彆為6.174和1.996 μmol/L.與DMSO處理組比較,GSK525762A處理後RS4; 11細胞c-myc、Bcl-2、CDK6mRNA轉錄水平降低,而Bad、Bak、Bax mRNA轉錄水平升高,且Bcl-2蛋白錶達水平下調,Bak蛋白錶達水平上調.而GSK525762A對Jurkat細胞的增殖抑製作用併不明顯.結論 GSK525762A可抑製RS4; 11細胞的增殖,併促進其凋亡;該作用可能通過下調Bcl-2錶達,誘導白血病細胞凋亡而實現的.
목적 탐구추결구역단백4(BRD4)억제제대급성B림파세포백혈병세포생물학행위적영향급가능궤제.방법 용BRD4억제제GSK525762A억제급성B림파세포백혈병세포주RS4; 11세포BRD4활성,병이급성T림파세포백혈병세포주Jurkat세포작대조.채용CCK-8법검측기대세포증식적영향;용Annexin Ⅴ/7-AAD표기,류식세포술검측세포조망;형광정량PCR검측항조망기인c-myc、Bcl-2、CDK6화촉조망기인Bad、Bak、Bax적전록수평;Western blot검측Bcl-2급Bak단백적표체.결과 불동농도GSK525762A대RS4; 11세포증식균유억제작용,차정시간화제량의뢰성,작용48、72 h기반수억제솔분별위6.174화1.996 μmol/L.여DMSO처리조비교,GSK525762A처리후RS4; 11세포c-myc、Bcl-2、CDK6mRNA전록수평강저,이Bad、Bak、Bax mRNA전록수평승고,차Bcl-2단백표체수평하조,Bak단백표체수평상조.이GSK525762A대Jurkat세포적증식억제작용병불명현.결론 GSK525762A가억제RS4; 11세포적증식,병촉진기조망;해작용가능통과하조Bcl-2표체,유도백혈병세포조망이실현적.
Objective To investigate the effect of bromdomain protein 4 (BRD4) inhibitor GSK525762A on the proliferation,apoptosis of B-cell acute lymphoblastic leukemia cell line RS4; 11 cells,and to further explore the mechanism.Methods Compared with Jurkat leukemia cells,the activity of BRD4 on RS4; 11 cells were inhibited by the inhibitor GSK525762A.The inhibitory effects of BRD4 on RS4; 11 cells were measured by CCK-8 test and the apoptosis of those cells was determined by Annexin Ⅴ/7-AAD dyeing using flow cytometry.The transcripts of anti-apoptotic genes c-myc,Bcl-2,CDK6 and proapoptotic genes Bad,Bak,Bax were detected by quantitative PCR,and the expression of Bcl-2 and Bak proteins were detected via Western blot.Results Proliferation of RS4;11 cells could be inhibited by GSK525762A in a time-and dose-dependent manner,and the inhibitory IC50 at 48 and 72 h was 6.174 and 1.996 μmol/L,respectively.Compared with DMSO in control group,the levels of c-myc,Bcl-2 and CDK6 mRNA transcripts in RS4; 11 cells were reduced in GSK525762A treated group,while the levels of Bad,Bak,Bax mRNA transcripts were enhanced,moreover,Bcl-2 protein levels decreased and Bak protein levels increased.However,the inhibitory effect of GSK525762A on Jurkat cells proliferation was not obvious.Conclusion GSK525762A can inhibit the proliferation of RS4;11 cells and promoted cells apoptosis.The possible mechanisms underlying this phenomenon might be achieved via downregulation of Bcl-2 protein induced apoptosis of leukemia cells.